Pulmonary tuberculous cavities in diabetic patients: Glycemic control is still the dominant factor despite the emerging role of metformin. Issue 8 (August 2019)

• Record Type: Journal Article
• Authors: Huang, Li-Kuo; Jiang, Liang-De; Lai, Yi-Chun; Wu, Mei-Han; Chang, Shi-Chuan
• Is Part Of: Journal of the Chinese Medical Association. Volume 82:Issue 8(2019)
• Publication Date: 2019-08
• Subjects: Diabetes mellitus -- Hemoglobin A1c -- Metformin -- Tuberculosis; Medicine -- Periodicals; 610.5
• DOI: 10.1097/JCMA.0000000000000132
• Languages: English
• ISSNs: 1726-4901

Abstract

Abstract : Background: Previous studies have reported an increased risk of cavities in diabetic patients with pulmonary tuberculosis (PTB), which may be associated with poor glycemic control. Cavities have a negative impact on PTB treatment outcomes; however, the possible interaction of other potentially confounding diabetes-related variables regarding pulmonary cavities have not been fully evaluated. Methods: We conducted a retrospective cohort study of diabetic patients with culture-proven PTB. The patients' chest X-rays (CXRs) and computed tomography (CT) scans were reviewed to assess the effects of clinical factors, glycosylated hemoglobin (HbA1c) levels, and antidiabetic agents on cavitary lesions. Results: Among 128 diabetic PTB patients, those with pulmonary cavities on CXRs and CT scans presented younger ages, lack of metformin treatment, and significantly higher HbA1c levels than those without cavities. Multivariate logistic regression analysis revealed significantly higher HbA1c levels in patients with cavities than in those without cavities on CXRs (odds ratio [OR], 1.34; 95% confidence interval [CI], 1.12-1.61) and CT scans (OR, 1.36; 95% CI, 1.13-1.64). Patients with multiple cavities had significantly higher HbA1c levels than those with a single cavity on CT scans ( p = 0.002). No significant differences in other variables, including metformin treatment, were noted between the groups. Conclusion: This study suggests that despite multiple potential confounding variables, including metformin use, poor glycemic control is still the dominant risk factor for cavitary lesions in diabetic patients with PTB. Efforts to improve glycemic control in diabetic PTB patients may be of considerable value in facilitating antimycobacterial treatment.